Plasma derived (PD) and recombinant (R) factor VIII (FVIII) concentrates induce a different rate of inhibitor development in hemophilia A patients. a systematic review of the literature Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • July 2009